Vaccine Diplomacy - International Communication | Học viện Ngoại giao Việt Nam

Vaccine Diplomacy - International Communication | Học viện Ngoại giao Việt Nam được sưu tầm và soạn thảo dưới dạng file PDF để gửi tới các bạn sinh viên cùng tham khảo, ôn tập đầy đủ kiến thức, chuẩn bị cho các buổi học thật tốt. Mời bạn đọc đón xem!

Viewpoints
‘‘Vaccine Diplomacy’’: Historical Perspectives and Future
Directions
Peter J. Hotez
1,2,3
*
1 Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National
School of Tropical Medicine at Baylor College of Medicine, Houston, Texas, United States of America, 2 Departments of Medical Humanities and Biology, Baylor University,
Waco, Texas, United States of America, 3 James A. Baker III Institute for Public Policy, Rice University, Houston, Texas, United States of America
Vaccine diplomacy is the branch of global
health diplomacy that relies on the use or delivery
of vaccines, while vaccine science diplomacy is a
unique hybrid of global health and science
diplomacy. Both offer innovative opportunities to
promote United States (US) foreign policy and
diplomatic relations between adversarial nations.
Vaccine science diplomacy could also lead to the
development and testing of some highly innovative
neglected disease vaccines.
Introduction: Origins and
Definitions
International cooperation for purposes
of infectious and tropical disease control
goes back to at least the 14th century,
when early concepts of quarantine were
introduced in Dubrovnik on the Adriatic
Coast of Croatia [1,2], and to the later
date of 1851, when Europe held its first
International Sanitary Conference for
multilateral cooperation to prevent the
spread of cholera and, subsequently,
plague and yellow fever [3]. Such efforts
led to a series of international sanitary
treaties and conventions and ultimately to
the formation of the Pan American Health
Organization and the later establishment
of the World Health Organization (WHO)
[3,4].
Some scholars trace our current frame-
work for global health diplomacy to the
writings of Dr. Peter G. Bourne in his role
as special assistant for health issues to US
President Jimmy Carter [5] and later
(during the first years of the 21st century)
to the launch of the Millennium Develop-
ment Goals (MDGs) and the release of the
‘‘Report of the Commission for Macro-
economics and Health’’, when global
health was placed squarely in the interna-
tional diplomacy arena [6]. Among the
driving forces for these activities was an
urgent need for diplomatic collaboration
to combat pandemics caused by HIV/
AIDS and seasonal and avian influenza,
which came with the revelation that such
diseases are threats to economic develop-
ment and both national security and
foreign policy interests [7]. There were
also practical considerations concerning
potential bioterrorist threats and situations
that required international diplomacy,
such as when Indonesia balked at sharing
its time-sensitive avian influenza data or
when Nigeria and Pakistan halted polio
and other immunization initiatives be-
cause of religious tensions [7–11].
In 2007, foreign ministers from seven
countries—Brazil, France, Indonesia, Nor-
way, Senegal, South Africa, and Thai-
land—issued the landmark ‘‘Oslo Minis-
terial Declaration’’ that formally linked
global health to foreign policy [12]. At that
time, Kickbusch et al. defined global
health diplomacy in terms of processes
by which governments and civil societies
both ‘‘position health in foreign policy
negotiations’’ and create new types of
‘‘global health governance’’ [13,14]. More
recently, Kickbusch and Lokeny defined it
as a ‘‘system of organization and commu-
nications and negotiation processes that
shape global policy environment in the
sphere of health and its determinants’’
[15].
A key element of modern global health
diplomacy is that ‘‘no longer do diplomats
just talk to other diplomats’’, but instead a
variety of experts in different areas and
disciplines are now brought in to solve
timely global health issues [13]. Katz et al.
[9] have since categorized different aspects
of global health diplomacy to include the
following: (1) core diplomacy, referring to
‘‘classical Westphalian negotiations’’ be-
tween nations leading to bilateral and
multilateral treaties, such as the recent
WHO Framework Convention on Tobac-
co Control and International Health
Regulations (IHR) 2005; (2) multistake-
holder diplomacy, i.e., negotiations be-
tween or among nations and international
agencies such as WHO, the GAVI Alli-
ance, United States Agency for Interna-
tional Development (USAID), and non-
governmental organizations (NGOs); and
(3) informal diplomacy, which includes
peer-to-peer scientific partnerships, private
funders such as the Bill & Melinda Gates
Foundation, and even some government
employees from USAID or the US
military working more or less indepen-
dently in the field due to unique circum-
stances [9]. Michaud and Kates have
identified similar forms of global health
diplomacy [16].
Kickbusch and Lokeny have also noted
recently that the WHO director-general
made frequent mention of health diplo-
macy in her remarks at the January 2013
executive session [15]. Among the factors
responsible for this emphasis are global-
ization associated with the renewed em-
phasis on ‘‘soft power’’, security policy,
trade agreements, and policies concerning
the environment and international devel-
opment, as well as the inclusion of health
issues as part of the United Nations and
summits held by various government
organizations and agencies, such as the
Group of Eight (G8) and Group of Twenty
(G20) nations, the European Union (EU),
the Organization of the Islamic Confer-
ence (OIC), and the BRICS (Brazil,
Citation: Hotez PJ (2014) ‘‘Vaccine Diplomacy’’: Historical Perspectives and Future Directions. PLoS Negl Trop
Dis 8(6): e2808. doi:10.1371/journal.pntd.0002808
Editor: Sara Lustigman, Lindsley F. Kimball Research Institute, New York Blood Center, United States of
America
Published June 26, 2014
Copyright: ß 2014 Peter J. Hotez. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
Funding: The author has indicated that no funding was received for this work.
Competing Interests: The author has read the journal’s policy and has the following conflicts: The author is
principal investigator and patent holder on vaccines in development or clinical trials for hookworm, Chagas
disease, leishmaniasis, schistosomiasis, SARS, ascariasis, and trichuriasis. This does not alter our adherence to all
PLOS policies on sharing data and materials.
* Email: hotez@bcm.edu
PLOS Neglected Tropical Diseases | www.plosntds.org 1 June 2014 | Volume 8 | Issue 6 | e2808
23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions
about:blank
1/7
Russia, India, China, and South Africa)
countries [15]. Still another factor is the
increasing use of health attache´s embed-
ded in foreign delegations and agencies
and increasing dialogue with low- and
middle-income countries [15]. With re-
gards to the G20 (and their BRICS-
country components), I introduced the
term ‘‘blue marble health’’ to refer to the
unexpectedly high neglected disease bur-
den among the poor living in emerging
economies and even some G20 countries,
circumstances such that these nations
could drastically reduce global burdens of
neglected diseases by taking greater re-
sponsibility for their own health concerns
[17,18].
Vaccine Diplomacy and Vaccine
Science Diplomacy: Definitions
Beginning in 2001, the broad frame-
work of global health diplomacy outlined
above helped to generate the concepts of
vaccine diplomacy and vaccine science
diplomacy [19–24]. Vaccine diplomacy
refers to almost any aspect of global health
diplomacy that relies on the use or delivery
of vaccines and encompasses the impor-
tant work of the GAVI Alliance, as well as
elements of the WHO, the Gates Foun-
dation, and other important international
organizations. Central to vaccine diplo-
macy is its potential as a humanitarian
intervention and its proven role in medi-
ating cessation of hostilities and even
cease-fires during vaccination campaigns
[20–22,25]. In this case, the lead actor
may come from an international organi-
zation, such as WHO or the United
Nations Children’s Fund (UNICEF), or
an associated nongovernmental organiza-
tion.
A subset of vaccine diplomacy is vaccine
science diplomacy, which is a hybrid of
elements of global health diplomacy and
science diplomacy. I use the term ‘‘vaccine
science diplomacy’’ narrowly to refer to
the joint development of life-saving vac-
cines and related technologies, with the
major actors typically scientists. Of partic-
ular interest, the scientists may be from
two or more nations that often disagree
ideologically or even from nations that are
actively engaged in hostile actions. This
definition is along the lines of what Katz et
al. would call informal global health
diplomacy based on peer-to-peer scientific
interactions [9], together with elements of
science diplomacy in which the represen-
tative nation projects power through its
scientific prowess and reputation, as Abel-
son and others articulated for US science
and applied technology during the Cold
War [26–28] or more recently as can be
seen in outreach to the Islamic world [29]
and targeted initiatives for less developed
countries [30]. Unlike many forms of
global health diplomacy, this aspect of
vaccine diplomacy is led by scientists.
An underlying theme of both vaccine
and vaccine science diplomacies is that
vaccines are unique in comparison to
other medical or public health interven-
tions. By some estimates, vaccines are the
single most powerful intervention ever
developed by humankind in terms of the
lives that they save. By one estimate,
modern vaccines have saved more lives
than those that were lost in the world wars
during the 20th century [21–23].
The Historical Context
Both vaccine diplomacy and vaccine
science diplomacy might be best under-
stood by reviewing their historical success-
es (Table 1). Indeed, an interesting but
little-known feature is how diplomacy is
intimately tied to the initial development
and delivery of many vaccines.
The first vaccine discovered in modern
times was in 1798 by Britain’s Edward
Jenner, who found that cowpox adminis-
tered as an inoculum could prevent
smallpox [31]; the term vaccine is derived
from vacca, the Latin term for ‘‘cow’’.
Because smallpox produced such devas-
tating and massive killer epidemics (espe-
cially among indigenous populations in the
New World), the first vaccine almost
immediately attained international ac-
claim in the first years of the 19th century
[31,32]. For example, from 1800 to 1805,
Jenner corresponded widely and interna-
tionally and advised countries as diverse as
Russia, Spain, and Turkey and Native
American tribes and nations in Canada
and Mexico on how to prepare and
administer the smallpox vaccine [31,32].
Among the earliest examples of vaccine
diplomacy, in 1801 Dr. Edward Gantt, the
chaplain of the US Congress, vaccinated
Native American diplomats who were
visiting Washington, D.C., and in 1803
the Lewis and Clark Expedition was
provided smallpox vaccine intended for
Native Americans living on the western
frontier, although it is unclear if successful
vaccinations were actually performed [32].
From 1803 to 1815 during the Napoleonic
wars between England and France, Jenner
himself was called on for diplomatic
functions, including prisoner releases
[31]. Jenner was honored in France and
wrote in a letter to the National Institute of
France that ‘‘the sciences are never at
war,’’ while Napoleon was supposed to
have once stated, ‘‘Jenner—we can’t
refuse that man anything’’ [19,31].
The next set of vaccines, including a
new rabies vaccine, was developed almost
one hundred years later by France’s Louis
Pasteur. In a speech at the inauguration of
his institute in Paris in 1888, Pasteur stated
that ‘‘science knows no country, because
knowledge belongs to humanity and is the
torch which illuminates the world’’
[31,33]. Before the close of the century,
scientists from the Pasteur Institute spread
out to create a network of laboratories in
Francophone countries in Indochina (be-
ginning with the Saigon Pasteur Institute
[1891]) and North Africa [34], especially
for the preparation and administration of
rabies vaccine. Around this time (from
1892–1897), Dr. Waldemar Haffkine, a
Jewish scientist from Ukraine working in
France and Switzerland, traveled to India
in order to inoculate tens of thousands of
people with his prototype cholera and
plague vaccines, but he did so only after
first testing the vaccines on himself [35].
Today, the Haffkine Institute in Mumbai
is an important microbiology research
institute.
Vaccine science diplomacy entered its
golden age during the Cold War between
the US and the Union of Soviet Socialist
Republics (USSR). Between 1956 and
1959, Dr. Albert Sabin from the US
traveled to the USSR and collaborated
with his Soviet virology counterparts,
including Dr. Mikhail Chumakov, to
develop a prototype oral polio vaccine
and test it on 10 million Soviet children
and ultimately 100 million people under
the age of 20 [36]. The success of the
collaboration depended on each scientist
going to great lengths to convince their
diplomatic liaisons to put aside ideologies
for purposes of joint scientific cooperation
[19–23,36]. Today, the oral polio vaccine
is leading to global eradication efforts.
Similarly, between 1962 and 1966, the
USSR pioneered a freeze-drying tech-
nique for smallpox vaccine and provided
450 million doses of vaccine to support
global smallpox eradication campaigns in
developing countries, while the US pro-
vided key financial support [37]. Such
international collaborative efforts led to
the global eradication of smallpox by the
late 1970s, an effort led by Dr. D. A.
Henderson [37]. Later, in the 1980s and
following the visit of US Nobel Laureate
Fred Robbins to India, the Indo-US
Vaccine Action Program (VAP) was es-
tablished to foster international collabora-
tion in the areas of epidemiology, labora-
tory investigation, and vaccine clinical
trials, quality control, and delivery [38].
PLOS Neglected Tropical Diseases | www.plosntds.org 2 June 2014 | Volume 8 | Issue 6 | e2808
23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions
about:blank
2/7
Table 1. Historical milestones in vaccine diplomacy.
Years Specific Vaccine(s) Actions Reference
1800–1805 Smallpox Edward Jenner promotes vaccine use in Russia, Turkey, and Spain and with Native Americans
in the Spanish colonies of Mexico, the Five Nations of Canada, and the United States.
[31,32]
1801 Smallpox The chaplain of Congress, Dr. Edward Gantt, vaccinates Native American diplomats visiting
Washington, D.C.
[32]
1803 Smallpox The Lewis and Clark Expedition provides vaccine intended for Native Americans, but it is
unclear if successful vaccinations were performed.
[32]
1803–1815 Smallpox During the Napoleonic Wars, Jenner calls for prisoner release and other diplomatic functions.
In a letter to the National Institute of France, he writes that ‘‘the sciences are never at war.’’
[31]
1851 - The First International Sanitary Conference is held in Europe. [3]
1888 - In a speech on the inauguration of the Pasteur Institute, Louis Pasteur states, ‘‘Science knows
no country, because knowledge belongs to humanity and is the torch which illuminates the
world.’’
[31,33]
1891–present - International network of Pasteur Institutes begins, initially in Saigon, for purposes of
fundamental research and research on vaccines for rabies and other infectious diseases.
[34]
1892–1897 Cholera and plague After first testing the vaccines on himself, Dr. Waldemar Haffkine travels to India to inoculate
tens of thousands of people with his prototype cholera and plague vaccines.
[35]
1902 - Formation of the International Sanitary Bureau (present-day Pan American Health
Organization)
[4]
1946–48 - Formation of the World Health Organization [3]
1956–1959 Polio Dr. Albert Sabin travels to the USSR and collaborates with Dr. Mikhail Chumakov, ultimately
testing an oral vaccine on 10 million children and then on 100 million people under the age
of 20.
[36]
1962–1966 Smallpox The USSR provides 450 million doses of vaccine for an eradication campaign, while the US
provides financial support.
[37]
1968 - Formation of the Fogarty International Center of the NIH
Mid-1970s Formation of PATH
1980s and 1990s Polio and other vaccines ‘‘Days of tranquility’’ for immunizations are held in more than a dozen war-torn countries. [25]
1987 - Indo-US Vaccine Action Program (VAP) is administered under the auspices of NIAID, NIH. [38]
1990–91 - Children’s Vaccine Initiative (CVI)
1993 - Formation of the Sabin Vaccine Institute [58]
- Formation of the Infectious Diseases Research Institute
1997 - Formation of the International Vaccine Institute
1997 - Formation of the Bill & Melinda Gates Foundation
2000 - GAVI Alliance is established, ultimately providing vaccines for North Korea. [39,41]
2001 - ‘‘Vaccine diplomacy’’ enters the literature. [19]
2007 Formation of program in Sustainable Immunization Financing at Sabin Vaccine Institute [65]
2007 Influenza Under the auspices of the WHO, Brazil, India, Indonesia, Mexico, Thailand, and Vietnam
receive US and Japanese grants for influenza vaccine manufacturing capacity and technology
transfer.
[52]
2008 Yellow Fever Outbreak of urban yellow fever—the neighboring countries of Paraguay mobilize to ensure
access to yellow fever vaccine.
[45]
2009 H1N1 Influenza A Intergovernmental Meeting (IGM) on Pandemic Influenza Preparedness Framework for the
Sharing of Influenza Viruses and Access to Vaccines and Other Benefits
[43]
2010 Cholera Call for international cholera vaccine stockpile as a humanitarian and diplomatic resource [44]
2011 - Decade of Vaccines Collaboration [46]
2012 - The Global Vaccine Action Plan (GVAP)—endorsed by the 194 Member States of the World
Health Assembly in May 2012
[47,48]
2013 Leishmaniasis and other
neglected tropical diseases
Joint statement on vaccine diplomacy between US and Iran [54]
2013 - State Department forms new Office of Global Health Diplomacy.
doi:10.1371/journal.pntd.0002808.t001
PLOS Neglected Tropical Diseases | www.plosntds.org 3 June 2014 | Volume 8 | Issue 6 | e2808
23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions
about:blank
3/7
VAP is maintained under the auspices of
the National Institute of Allergy and
Infectious Diseases of the US National
Institutes of Health (NIH) [38]. In 1990–
91, a Children’s Vaccine Initiative was
launched as an early attempt at global
governance for developing pediatric vac-
cines for developing countries.
Vaccine diplomacy also flourished in
the later decades of the 20th century.
According to WHO’s Health as a Bridge
to Peace—Humanitarian Cease-Fires
Project (HCFP), vaccines and vaccinations
were used to negotiate so-called ‘‘days of
tranquility’’ in more than a dozen coun-
tries during the 1980s and 1990s, includ-
ing Afghanistan, Angola, Chechnya, Dem-
ocratic Republic of Congo, El Salvador,
Guinea Bissau, Iraq, Lebanon, Philip-
pines, Sierra Leone, Sri Lanka, and Sudan
[25].
Modern Day Vaccine and
Vaccine Science Diplomacy
Beginning in 2000, vaccines became
integrated as key tools in helping develop-
ing nations achieve their MDGs and
targets. Following the launch of the GAVI
Alliance, many developing countries for
the first time gained access to vaccines for
combating rotavirus and Haemophilus influ-
enzae type b (Hib), and a new vaccine for
pneumococcal vaccine was developed
[39,40]. Partly because of these interven-
tions, child mortality was reduced by
almost one-half [40]. Included among
these activities was GAVI’s important
work in providing vaccines for North
Korea and other fragile states [41].
Among the initiatives relevant to vac-
cine diplomacy in the 21st century are
international efforts to ensure universal or
equitable access for low- and middle-
income countries to urgently needed
vaccines for diseases of pandemic poten-
tial. It was noted that many developing
countries were on the ‘‘outside looking in’’
when it came to having access to influenza
vaccines, including the vaccine for the
H1N1 pandemic influenza in 2009 and
prototype H5N1 avian influenza vaccines
[42,43]. As a result, Indonesia went
through a period in which it refused to
share timely influenza surveillance data
with the WHO [42]. It was noted that
IHR 2005 did not adequately spell out
provisions on providing equitable access
for vaccines [43], and it was probably not
intended for this purpose. In 2009, an
Intergovernmental Meeting (IGM) was
held on pandemic influenza preparedness
as a means to establish a framework for
sharing influenza and other vaccines with
developing countries [43]. Issues of devel-
oping country access again arose when
cholera emerged in sub-Saharan Africa
and Haiti; there was no mechanism to
rapidly mobilize cholera vaccine, and calls
went out to stockpile cholera vaccine as a
humanitarian and diplomatic resource
[44]. Also, in 2008 when yellow fever
vaccine supplies were depleted during the
first urban yellow fever outbreak in the
Americas in decades, countries neighbor-
ing Paraguay helped to ensure that the
vaccine was made available in that
country [45]. In 2012, following the earlier
launch of the Decade of Vaccines Collab-
oration [46], the Global Vaccine Action
Plan (GVAP) was endorsed by the 194
Member States of the World Health
Assembly as ‘‘a framework to prevent
millions of deaths by 2020 through more
equitable access to existing vaccines for
people in all communities’’ [47]. A World
Health Assembly resolution was adopted
that recognizes access to vaccines as a
fundamental right to human health [48].
The diplomatic community was also called
on to address critical issues of noncompli-
ance for polio and other vaccines intended
for vulnerable populations living in Islamic
countries. In 2003, a boycott of polio
vaccinations in three northern Nigerian
states from fears that the vaccine was
contaminated with antifertility drugs (in
order to sterilize Muslim girls) necessitated
diplomatic intervention from the Govern-
ment of Malaysia and the OIC [49].
Similar interventions are now required in
Pakistan, where the Taliban and other
extremist groups have assassinated vacci-
nators and other aid workers [50]. Some
assassinations may have been carried out
in retaliation for the Central Intelligence
Agency (CIA)’s alleged role in establishing
a fake vaccination campaign in Abbotta-
bad, Pakistan, as a ruse in order to confirm
the identity of members of Osama bin
Laden’s family [51]. Such activities repre-
sent a significant setback to vaccine
diplomacy.
Of relevance to both vaccine and
vaccine science diplomacy, in 2007 under
the auspices of the WHO and the Global
Pandemic Influenza Action Plan, six
countries—Brazil, India, Indonesia, Mex-
ico, Thailand, and Vietnam—received
grants from the US and Japanese govern-
ments to establish in-country manufactur-
ing capacity for influenza vaccines [52].
Future Directions and Moving
towards a Framework
While the historical and modern-day
track records of vaccine and vaccine
science diplomacy are impressive, they
have not yet led to an overarching
framework for its expanded role in foreign
policy. Establishing such a framework
might be especially useful for US foreign
policy.
In 2009, President Obama traveled to
Cairo where he spoke out about engaging
scientists in the Muslim world and extend-
ing a hand in science diplomacy [53].
Despite the establishment of a valuable US
Science Envoy program, to date such
activities have not led to substantive joint
vaccine partnerships despite the observa-
tion that several Islamic countries in the
Middle East and Asia, including Egypt,
Indonesia, Iran, and Saudi Arabia, have
some capacity for vaccine product devel-
opment [23]. With an Iranian scientist
from the Tehran University of Medical
Sciences, Dr. Mohammed Rokni, I re-
cently advocated launching such efforts
between the US and Iran and provided as
an example the opportunity for developing
a vaccine for leishmaniasis, which has
devastated areas of conflict in the Middle
East and North Africa [54]. Similar
opportunities exist in order to partner
with nations such as Cuba, which has
considerable technical expertise both in
producing and delivering vaccine [55],
and possibly even countries such as North
Korea, which has some technical capabil-
ities [56].
Our Sabin Vaccine Institute and Texas
Children’s Hospital Center for Vaccine
Development (Sabin), a nonprofit product
development partnership (PDP) that uses
industry practices to develop and test
neglected disease vaccines, could occupy
a key niche in vaccine diplomacy. Sabin’s
vaccine portfolio targets neglected tropical
diseases (NTDs) that specifically affect the
poorest people living in low- and middle-
income countries. Because NTDs have
been shown to promote poverty through
their adverse effects on worker productiv-
ity, the health of girls and women, and
child development, the vaccines under
development at Sabin are sometimes
referred to as the ‘‘antipoverty vaccines’’
[57,58]. Moreover, most of the diseases
targeted by the Sabin portfolio of vaccines
occur in countries of direct relevance to
vaccine diplomacy (Table 2) [59]. For
example, more than one-third of the
world’s cases of hookworm infection,
ascariasis, and trichuriasis occur in nations
of the OIC, i.e., the world’s Muslim
countries (Figure 1), while almost one-half
of the cases of schistosomiasis occur
among the OIC countries [59]. Further-
more, both cutaneous and visceral leish-
maniasis have emerged as the most
PLOS Neglected Tropical Diseases | www.plosntds.org 4 June 2014 | Volume 8 | Issue 6 | e2808
23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions
about:blank
4/7
significant infections arising in settings of
ongoing conflict, with the former affecting
hundreds of thousands of people in Syria
and Syrian refugees, while the latter was
the leading killer in the war between
northern and southern Sudan during the
1980s and 1990s [60]. Some of these
diseases are also widespread in some Latin
American countries where leaders have
expressed varying degrees of anti-Ameri-
can sentiment. While Sabin is currently
conducting joint vaccine development
with public-sector vaccine manufacturers
in Brazil and Mexico, it is ready to embark
on joint vaccine development with coun-
tries such as Cuba, Indonesia, and Iran,
i.e., nations with either strained or even
overtly hostile foreign relations with the
US in past and recent years. As a form of
projecting soft power with both allies and
potential adversaries, such activities are
consistent with what former Secretary
Hillary Clinton termed ‘‘civilian power’’
[24].
Beyond US foreign relations, there are
opportunities for vaccines to promote
cooperation between Asian nations. For
instance, each of the largest Asian coun-
tries, i.e., China, India, Indonesia, Japan,
and Vietnam, has capabilities to develop
and produce new vaccines [56,61]. China
and India engaged in overt hostilities in
1964, while China’s recent territorial
claims in the East China Sea have sparked
fresh tensions in the region [61]. Both
Sabin and another PDP, the International
Vaccine Institute (IVI) based in Seoul,
Korea [62], could help mediate vaccine
diplomacy between these nations. In
addition, Brazil, which also has major
vaccine capabilities, has initiated South-
South partnerships with Lusophone Africa
and could become an important actor in
vaccine diplomacy [63]. Vaccine manu-
facturing organizations associated with
many of the key OIC and Asian nations
targeted for vaccine science diplomacy
belong to the unique Developing Coun-
tries Vaccine Manufacturers Network
(DCVMN) [64]. Both the GAVI Alliance
and WHO could have key roles in
coordinating these activities. These orga-
nizations also have a key role in a
new Sustainable Immunization Financing
Figure 1. The OIC member nations. Figure adapted from Wikipedia: http://en.wikipedia.org/wiki/File:OIC_map.png.
doi:10.1371/journal.pntd.0002808.g001
Table 2. Sabin PDP vaccines under development of potential relevance to US foreign policy interests.
Disease Targeted (Approximate Number of
People Affected)
Affected Geographic Areas of Interest to US
Foreign Policy Interests Stage of Development
Human hookworm infection (400 million) OIC countries in Africa, the Middle East, and Asia Phase 1
India and China
Schistosomiasis (250 million) OIC countries in Africa and the Middle East Completed current good manufacturing practice (cGMP)
manufacture
Ascariasis and Trichuriasis (.800 million) OIC countries in Africa, the Middle East, and Asia Preclinical
India and China
Leishmaniasis (10 million) Areas of conflict in the Middle East and North Africa,
including OIC countries
Preclinical
Chagas disease (7–8 million) Venezuela, Ecuador, Bolivia Preclinical
SARS (None currently) China Preclinical
doi:10.1371/journal.pntd.0002808.t002
PLOS Neglected Tropical Diseases | www.plosntds.org 5 June 2014 | Volume 8 | Issue 6 | e2808
23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions
about:blank
5/7
program inaugurated with Gates Founda-
tion support by Dr. Ciro De Quadros at
the Sabin Vaccine Institute, which focuses
on 12 African countries, five Asian coun-
tries, and one Central Asian country [65].
Today, the Division of International
Relations of the NIH’s Fogarty Interna-
tional Center maintains an important
role in promoting international agree-
ments between the US and governments
throughout the world [66]. In the coming
years, vaccine and vaccine science diplo-
macy activities could become incorporated
into the new US State Department Office
of Global Health Diplomacy [67], as well
as into the WHO and its regional offices
and within organizations such as the Bill &
Melinda Gates Foundation and the Carlos
Slim Health Institute. The power of
vaccine and vaccine science diplomacy
has been underexplored despite a noble
track record that included promoting
peace between the Cold War powers of
the 1950s and 1960s, which also led to the
development, testing, and delivery of two
of the most important 20th century health
interventions, i.e., the freeze-dried small-
pox vaccine and oral polio vaccine, and
the resulting global eradication of small-
pox and near elimination of polio. The
historical lessons from these accomplish-
ments still have critical relevance to global
health and blue marble health.
References
1. Tognotti E (2013) Lessons from the History of
Quarantine, from Plague to Influenza A. Emerg
Infect Dis 19: 254–259. Available: http://wwwnc.
cdc.gov/eid/article/19/2/12-0312_article.htm.
Accessed 7 December 2013.
2. Feldbaum H, Lee K, Michaud J (2010) Global
health and foreign policy. Epidemiol Rev 32: 82–
92
3. Fidler DP (2001) The globalization of public
health: the first 100 years of international health
diplomacy. Bull World Health Organ 79: 842–
849.
4. Fee E, Brown T (2002) 100 years of the Pan
American Health Organization. Am J Publ
Health 92: 1888–1889.
5. Bourne PG (1978) A partnership for international
health care. Public Health Rep 93: 114–123.
6. Hotez PJ (2013) Forgotten People, Forgotten
Diseases: The Neglected Tropical Diseases and
their Impact on Global Health and Development.
2nd Edition. Washington (D.C.): ASM Press. 275
p.
7. Michaud J, Kates J (2013) Global health diplo-
macy: advancing foreign policy and global health
interests. Glob Health Sci Pract 1: 24–28.
8. Peterson S (2002) Epidemic disease and national
security. Security Studies 12: 43–81.
9. Katz R, Kornblet S, Arnold G, Lief E, Fischer JE
(2011) Defining health diplomacy: changing
demands in the era of globalization. Milbank Q
89: 503–523.
10. Kaufmann JR, Feldbaum H (2009) Diplomacy
and the polio immunization boycott in northern
Nigeria. Health Affairs 28: 1091–1101.
11. Fidler DP (2010) Negotiating equitable access to
influenza vaccines: global health diplomacy and
the controversies surrounding avian influenza
H5N1 and pandemic influenza H1N1. PLoS
Med 7: e1000247.
12. Foreign Ministers of Brazil, France, Indonesia,
Norway, Senegal, South Africa, and Thailand
(Oslo) (2007) Oslo Ministerial Declaration—
Global health: A pressing foreign policy issue of
our time. Lancet 369: 1373–1378.
13. Kickbusch I, Silberschmidt G, Buss P (2007)
Global health diplomacy: the need for new
perspectives, strategic approaches and skills in
global health. Bull World Health Organ 85: 230–
232.
14. Labonte R, Gagnon ML (2010) Framing health
and foreign policy: lessons for global health
diplomacy. Global Health 6: 14.
15. Kickbusch I, Lokeny M (2013) Global health
diplomacy: five years on. Bull World Health
Organ 91: 159–159A.
16. Michaud J, Kates J (2013) Global health diplo-
macy: advancing foreign policy and global health
interests. Glob Health Sci Pract 1: 24–28.
17. Hotez P (2013 March 25) The disease next door.
Foreign Policy. Availabl e : http:// w w w .
foreignpolicy.com/articl es/2013/03/25/the_
disease_next_door. Accessed 29 May 2014.
18. Hotez PJ (2013) NTDs V.2.0: ‘‘Blue Marble
Health’’—Neglected Tropical Disease Control
and Elimination in a Shifting Health Policy
Landscape. PLoS Negl Trop Dis 7: e2570.
19. Hotez PJ (2001 May–Jun) Vaccine diplomacy.
Foreign Policy 124: 68–69.
20. Hotez PJ (2001) Vaccines as instruments of
foreign policy. EMBO Rep 2: 862–868.
21. Hotez P (2002) Appeasing Wilson’s Ghost: The
expanded role of the new vaccines in internation-
al diplomacy. In: CBACI Health and Security
Series. Occasional Paper 3. Washington (D.C.):
Chemical and Biological Arms Control Institute.
22. Hotez PJ (2006) The ‘‘biblical diseases’’ and US
vaccine diplomacy. Brown J World Affairs 12:
247–258.
23. Hotez PJ (2010) Peace through vaccine diploma-
cy. Science 327: 1301.
24. Hotez PJ (2011) Unleashing ‘‘civilian power’’: a
new American diplomacy through neglected
tropical disease control, elimination, research,
and development. PLoS Negl Trop Dis 5: e1134.
25. World Health Organization (2014) Health as a
Bridge for Peace - HUMANITARIAN CEASE-
FIRES PROJECT (HCFP). Available: http://
www.who.int/hac/techguidance/hbp/cease_
fires/en/#. Accessed 25 January 2014.
26. Abelson PH (1972) Science, technology, and
diplomacy. Science 178: 701.
27. Rabkin YM (1988) Sciences between the super-
powers. New York: Priority Press. 119 p.
28. Schweitzer GE (1989) Techno-Diplomacy: US-
Soviet Confrontations in Science and Technolo-
gy. New York: Plenum Pub Corp. 320 p.
29. Zewall AH (2010) Science in diplomacy. Cell 141:
204–207
30. Federoff NV (2009) Science diplomacy in the 21st
century. Cell 136: 9–11.
31. Bazin H (2000) The Eradication of Smallpox:
Edward Jenner and the First and Only Eradica-
tion of a Human Infectious Disease. New York:
Academic Press. 246 p.
32. Pearson JD (2004) Medical diplomacy and the
American Indian: Thomas Jefferson, the Lewis
and Clark Expedition, and the subsequent effects
on American Indian health and public policy.
Wicazo S Review 19: 105–130.
33. Chura L (2012) Global science can bolster
diplomacy. Nature 491: 527.
34. Pasteur International (2014) History in Move-
ment. Available: http://www.pasteur-inter
national.org/ip/easysite/pasteur-international-
en/i nstitu t -paste ur-int e rnatio n al- n etwork /
history-in-movement. Accessed 10 December
2013.
35. Waksman SA (1964) The Brilliant and Tragic
Life of WMW Haffkine, Bacteriologist. New
Brunswick (New Jersey): Rutgers University Press.
90 p.
36. Swanson W (2012) Birth of a cold war vaccine.
Sci Am 306: 66–69.
37. Henderson DA (2009) Smallpox: the death
of a disease. Amherst (New York): Prometheus
Books. 334 p.
38. NIAID (2012) Indo-U.S. Vaccine Action Pro-
gram (VAP). Available: http://www.niaid.nih.
gov/about/organization/dmid/indo/Pages/
default.aspx. Accessed 25 January 2014.
39. Gavi Alliance (2014) Gavi Alliance. Available:
http://www.gavialliance.org. Accessed 10 De-
cember 2013.
40. Hotez PJ (2013) Pediatric Tropical Diseases and
the World’s Children Living in Extreme Poverty.
J Appl Res Child 4: 10.
41. Gavi Alliance (2014) Korea, Democratic People’s
Republic of (the). Available: http://www.
gavialliance.org/country/dpr-korea. Accessed 10
December 2013.
Box 1. Potential Sites for Vaccine Diplomacy and US Foreign
Policy
A. Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine
Development, Houston, Texas, United States of America
B. International Vaccine Institute, Seoul, Korea
C. IDRI (Infectious Disease Research Institute), Seattle, Washington, United States
of America
D. PATH Vaccine Development Global Program, Washington, D.C., United
States of America
E. Finlay Institute, Havana, Cuba
F. Birmex, Mexico, D.F., Mexico
G. FIOCRUZ Bio-Manguinhos, Rio de Janeiro, Brazil
H. Instituto Butantan, Sao Paulo, Brazil
I. Vacsera, Cairo, Egypt
J. Razi Vaccine and Serum Institute and Institut Pasteur, Tehran, Iran
K. Biopharma, Bandang, Indonesia
PLOS Neglected Tropical Diseases | www.plosntds.org 6 June 2014 | Volume 8 | Issue 6 | e2808
23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions
about:blank
6/7
42. Fidler DP (2008) Influenza virus samples, inter-
national law, and global health diplomacy. Emerg
Infect Dis 14: 88–94
43. Fidler DP (2010) Negotiating equitable access to
influenza vaccines: global health diplomacy and
the controversies surrounding avian influenza
H5N1 and pandemic influenza H1N1. PLoS
Med 7: e1000247.
44. Waldor MK, Hotez PJ, Clemens JD (2010) A
national cholera vaccine stockpile a new
humanitarian a n d diplomatic r e s o u r c e .
N Engl J Med 363: 2279–2282.
45. Andrus JK, Ropero AM, Ghisays G, Romero S,
Jauregui B, et al. (2011) Yellow fever and health
diplomacy: International efforts to stop the urban
yellow fever outbreak in Paraguay. In: Rosskam
E, Kickbusch I, editors. Negotiating and Navi-
gating Global Health: Case Studies in Global
Health Diplomacy. Singapore: World Scientific
Publishing Company. pp. 391–403.
46. Decade of Vaccines (2014) Vision. Available:
http://www.dovcollabo /about-us/ration.org
vision/. Accessed 25 January 2014.
47. World Health Organization (2014) Decade of
Vaccines—Global Vaccine Action Plan 2011–
20 2 0. Av a i la b l e: h tt p : // w w w. w h o. in t /
immunization/global_vaccine_action_plan/en/.
Accessed 25 January 2014.
48. World Health Organization (2014) World Health
Assembly Resolution. Available: http://www.
who.int/immunization/global_ vaccine_action_
pl a n /G V A P__ W orl d _ Hea l th_ A s se m b ly_
Resolution.pdf. Accessed 25 January 2014
49. Kaufmann JR, Feldbaum H (2009) Diplomacy
and the polio immunization boycott in northern
Nigeria. Health Affairs 28: 1091–1101.
50. Scientific American (2013 April 16) How the
CIA’s Fake Vaccination Campaign Endangers Us
All. Available: http://www.scientificamerican.
com/article.cfm?id = how-cia-fake-vaccination-
campaign-endangers-us-all. Accessed 14 Decem-
ber 2013.
51. Shah S (2011 July 11) CIA organized fake
vaccination drive to get Osama bin Laden’s
family DNA. The Guardian. Available: http://
www.theguardian.com/world/2011/jul/11/cia-
fake-vaccinations-osama-bin-la dens-dna. Ac-
cessed 14 December 2013.
52. World Health Organization (2007 April 24)
WHO facilitates influenza vaccine technology
transfer to deve loping countries. Available:
http://who.int/mediacentre/news/notes/2007/
np18/en/index.html. Accessed 25 January 2014.
53. Koenig R (2009) US takes steps to use science to
improve ties to Muslim world. Science 326: 920–
921.
54. Hotez PJ, Rokni MB (2013 November 6) Next
steps in U.S.-Iran diplomacy: vaccines. Pacific
Standard. Available: http://www.psmag.com/
navigation/health-and-behavior/next-steps-u-s-
iran-diplomacy-vaccines-69542/. Accessed 29
May 2014.
55. Andrus JK, de Quadros CA, Castillo Slorzano C,
Roses Periago M, Henderson DA (2011) Measles
and rubella eradication in the Americas. Vaccine
295: D91–D96.
56. Hotez PJ (2013 January 24) A reunification Rx for
Korea. Los Angeles Times. Available: http://
articles.latimes.com/2013/jan/24/opinion/la-
oe-hotez-korea-vaccine-diplomacy-20130124.
Accessed 29 May 2014.
57. Hotez PJ, Ferris MT (2006) The antipoverty
vaccines. Vaccine 24: 5787–5799.
58. Hotez P (2011) A handful of anti poverty’
vaccines exist for neglected diseases, but the
world’s poorest billion people need more. Health
Aff (Millwood) 30: 1080–1087.
59. Hotez PJ (2009) The Neglected Tropical Diseases
and Their Devastating Health and Economic
Impact on the Member Nations of the Organi-
sation of the Islamic Conference. PLoS Negl
Trop Dis 3: e539. doi: 10.1371/journal.pntd.
0000539
60. Hotez PJ (2013 July 19) Another bad thing about
war: insect-borne diseases. Global Post. Available:
ht t p :// w w w.g lob a l pos t . com / d is pat c h es/
globalpost-blogs/commentary/insect-borne-
dis eases -wars -mideast- afric a-leishmani a s is-
chagas. Accessed 29 May 2014.
61. Hotez P, Singh SK, Zhou XN (2013) Advancing
Sino-Indian cooperation to combat tropical
diseases. PLoS Negl Trop Dis 7: e2204.
62. International Vaccine Initiative (2012) Training
and Technical Assistance. Available: http://
www.ivi.int/web/www/02_07_03. Accessed 14
December 2013.
63. Almedia C, Pires de Campos R, Buss P, Ferreira
JR, Fonseca LE (2009) Brazil’s conception of
South-South ‘‘structural cooperation’’ in health.
Fiocruz. Available: http://www6.ensp.fiocruz.br/
repositorio/sites/default/files/arquivos/343-
1635-2-PB.pdf. Accessed 14 December 2013.
64. DCVMN (2014) Members. Available: http://
www.dcvmn.org/members. Accessed 14 Decem-
ber 2013.
65. Sabin Vaccine Institute (2014) Sustainable Im-
munization Financing (SIF) Program. Available:
http:/ / w w w . sabin.org/pr o g r a ms/vaccine-
advocacy-education/sustainable-immunization-
financing-sif-program. Accessed 25 January 2014.
66. Fogarty International Center (2014) Division of
International Relations (DIR). Available: http://
www.fic.nih.gov/About/Staff/Pages/International-
Relations.aspx. Accessed 25 January 2014.
67. US Department of State (2014) Office of Global
Health Diplomacy. Available: http://www.state.
gov/s/ghd/. Accessed 14 December 2013.
PLOS Neglected Tropical Diseases | www.plosntds.org 7 June 2014 | Volume 8 | Issue 6 | e2808
23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions
about:blank
7/7
| 1/7

Preview text:

23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions Viewpoints
‘‘Vaccine Diplomacy’’: Historical Perspectives and Future Directions Peter J. Hotez1,2,3*
1 Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National
School of Tropical Medicine at Baylor College of Medicine, Houston, Texas, United States of America, 2 Departments of Medical Humanities and Biology, Baylor University,
Waco, Texas, United States of America, 3 James A. Baker III Institute for Public Policy, Rice University, Houston, Texas, United States of America
Vaccine diplomacy is the branch of global
potential bioterrorist threats and situations
WHO Framework Convention on Tobac-
health diplomacy that relies on the use or delivery
that required international diplomacy,
co Control and International Health
of vaccines, while vaccine science diplomacy is a
such as when Indonesia balked at sharing
Regulations (IHR) 2005; (2) multistake-
unique hybrid of global health and science
its time-sensitive avian influenza data or
holder diplomacy, i.e., negotiations be-
diplomacy. Both offer innovative opportunities to
when Nigeria and Pakistan halted polio
tween or among nations and international
promote United States (US) foreign policy and
and other immunization initiatives be-
agencies such as WHO, the GAVI Alli-
diplomatic relations between adversarial nations.
cause of religious tensions [7–11].
ance, United States Agency for Interna-
Vaccine science diplomacy could also lead to the
In 2007, foreign ministers from seven
tional Development (USAID), and non-
development and testing of some highly innovative
countries—Brazil, France, Indonesia, Nor-
governmental organizations (NGOs); and neglected disease vaccines.
way, Senegal, South Africa, and Thai-
(3) informal diplomacy, which includes
land—issued the landmark ‘‘Oslo Minis-
peer-to-peer scientific partnerships, private Introduction: Origins and
terial Declaration’’ that formally linked
funders such as the Bill & Melinda Gates Definitions
global health to foreign policy [12]. At that
Foundation, and even some government
time, Kickbusch et al. defined global employees from USAID or the US
International cooperation for purposes
health diplomacy in terms of processes
military working more or less indepen-
of infectious and tropical disease control
by which governments and civil societies
dently in the field due to unique circum-
goes back to at least the 14th century,
both ‘‘position health in foreign policy
stances [9]. Michaud and Kates have
when early concepts of quarantine were
negotiations’’ and create new types of
identified similar forms of global health
introduced in Dubrovnik on the Adriatic
‘‘global health governance’’ [13,14]. More diplomacy [16].
Coast of Croatia [1,2], and to the later
recently, Kickbusch and Lokeny defined it
Kickbusch and Lokeny have also noted
date of 1851, when Europe held its first
as a ‘‘system of organization and commu-
recently that the WHO director-general
International Sanitary Conference for
nications and negotiation processes that
made frequent mention of health diplo-
multilateral cooperation to prevent the
shape global policy environment in the
macy in her remarks at the January 2013
spread of cholera and, subsequently,
sphere of health and its determinants’’
executive session [15]. Among the factors
plague and yellow fever [3]. Such efforts [15].
responsible for this emphasis are global-
led to a series of international sanitary
A key element of modern global health
ization associated with the renewed em-
treaties and conventions and ultimately to
diplomacy is that ‘‘no longer do diplomats
phasis on ‘‘soft power’’, security policy,
the formation of the Pan American Health
just talk to other diplomats’’, but instead a
trade agreements, and policies concerning
Organization and the later establishment
variety of experts in different areas and
the environment and international devel-
of the World Health Organization (WHO)
disciplines are now brought in to solve
opment, as well as the inclusion of health [3,4].
timely global health issues [13]. Katz et al.
issues as part of the United Nations and
Some scholars trace our current frame-
[9] have since categorized different aspects
summits held by various government
work for global health diplomacy to the
of global health diplomacy to include the
organizations and agencies, such as the
writings of Dr. Peter G. Bourne in his role
following: (1) core diplomacy, referring to
Group of Eight (G8) and Group of Twenty
as special assistant for health issues to US
‘‘classical Westphalian negotiations’’ be-
(G20) nations, the European Union (EU),
President Jimmy Carter [5] and later
tween nations leading to bilateral and
the Organization of the Islamic Confer-
(during the first years of the 21st century)
multilateral treaties, such as the recent
ence (OIC), and the BRICS (Brazil,
to the launch of the Millennium Develop-
ment Goals (MDGs) and the release of the
Citation: Hotez PJ (2014) ‘‘Vaccine Diplomacy’’: Historical Perspectives and Future Directions. PLoS Negl Trop
‘‘Report of the Commission for Macro-
Dis 8(6): e2808. doi:10.1371/journal.pntd.0002808
economics and Health’’, when global
Editor: Sara Lustigman, Lindsley F. Kimball Research Institute, New York Blood Center, United States of
health was placed squarely in the interna- America
tional diplomacy arena [6]. Among the Published June 26, 2014
driving forces for these activities was an
urgent need for diplomatic collaboration
Copyright: ß 2014 Peter J. Hotez. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
to combat pandemics caused by HIV/
provided the original author and source are credited.
AIDS and seasonal and avian influenza,
Funding: The author has indicated that no funding was received for this work.
which came with the revelation that such
Competing Interests: The author has read the journal’s policy and has the following conflicts: The author is
diseases are threats to economic develop-
principal investigator and patent holder on vaccines in development or clinical trials for hookworm, Chagas
ment and both national security and
disease, leishmaniasis, schistosomiasis, SARS, ascariasis, and trichuriasis. This does not alter our adherence to all
foreign policy interests [7]. There were
PLOS policies on sharing data and materials.
also practical considerations concerning * Email: hotez@bcm.edu
PLOS Neglected Tropical Diseases | www.plosntds.org 1
June 2014 | Volume 8 | Issue 6 | e2808 about:blank 1/7 23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions
Russia, India, China, and South Africa)
War [26–28] or more recently as can be
have once stated, ‘‘Jenner—we can’t
countries [15]. Still another factor is the
seen in outreach to the Islamic world [29]
refuse that man anything’’ [19,31].
increasing use of health attache´s embed-
and targeted initiatives for less developed
The next set of vaccines, including a
ded in foreign delegations and agencies
countries [30]. Unlike many forms of
new rabies vaccine, was developed almost
and increasing dialogue with low- and
global health diplomacy, this aspect of
one hundred years later by France’s Louis
middle-income countries [15]. With re-
vaccine diplomacy is led by scientists.
Pasteur. In a speech at the inauguration of
gards to the G20 (and their BRICS-
An underlying theme of both vaccine
his institute in Paris in 1888, Pasteur stated
country components), I introduced the
and vaccine science diplomacies is that
that ‘‘science knows no country, because
term ‘‘blue marble health’’ to refer to the
vaccines are unique in comparison to
knowledge belongs to humanity and is the
unexpectedly high neglected disease bur-
other medical or public health interven- torch which illuminates the world’’
den among the poor living in emerging
tions. By some estimates, vaccines are the
[31,33]. Before the close of the century,
economies and even some G20 countries,
single most powerful intervention ever
scientists from the Pasteur Institute spread
circumstances such that these nations
developed by humankind in terms of the
out to create a network of laboratories in
could drastically reduce global burdens of
lives that they save. By one estimate,
Francophone countries in Indochina (be-
neglected diseases by taking greater re-
modern vaccines have saved more lives
ginning with the Saigon Pasteur Institute
sponsibility for their own health concerns
than those that were lost in the world wars
[1891]) and North Africa [34], especially [17,18].
during the 20th century [21–23].
for the preparation and administration of
rabies vaccine. Around this time (from Vaccine Diplomacy and Vaccine The Historical Context
1892–1897), Dr. Waldemar Haffkine, a Science Diplomacy: Definitions
Jewish scientist from Ukraine working in
Both vaccine diplomacy and vaccine
France and Switzerland, traveled to India
Beginning in 2001, the broad frame-
science diplomacy might be best under-
in order to inoculate tens of thousands of
work of global health diplomacy outlined
stood by reviewing their historical success-
people with his prototype cholera and
above helped to generate the concepts of
es (Table 1). Indeed, an interesting but
plague vaccines, but he did so only after
vaccine diplomacy and vaccine science
little-known feature is how diplomacy is
first testing the vaccines on himself [35].
diplomacy [19–24]. Vaccine diplomacy
intimately tied to the initial development
Today, the Haffkine Institute in Mumbai
refers to almost any aspect of global health and delivery of many vaccines.
is an important microbiology research
diplomacy that relies on the use or delivery
The first vaccine discovered in modern institute.
of vaccines and encompasses the impor-
times was in 1798 by Britain’s Edward
Vaccine science diplomacy entered its
tant work of the GAVI Alliance, as well as
Jenner, who found that cowpox adminis-
golden age during the Cold War between
elements of the WHO, the Gates Foun-
tered as an inoculum could prevent
the US and the Union of Soviet Socialist
dation, and other important international
smallpox [31]; the term vaccine is derived
Republics (USSR). Between 1956 and
organizations. Central to vaccine diplo-
from vacca, the Latin term for ‘‘cow’’.
1959, Dr. Albert Sabin from the US
macy is its potential as a humanitarian
Because smallpox produced such devas-
traveled to the USSR and collaborated
intervention and its proven role in medi-
tating and massive killer epidemics (espe-
with his Soviet virology counterparts,
ating cessation of hostilities and even
cially among indigenous populations in the
including Dr. Mikhail Chumakov, to
cease-fires during vaccination campaigns
New World), the first vaccine almost
develop a prototype oral polio vaccine
[20–22,25]. In this case, the lead actor
immediately attained international ac-
and test it on 10 million Soviet children
may come from an international organi-
claim in the first years of the 19th century
and ultimately 100 million people under
zation, such as WHO or the United
[31,32]. For example, from 1800 to 1805,
the age of 20 [36]. The success of the
Nations Children’s Fund (UNICEF), or
Jenner corresponded widely and interna-
collaboration depended on each scientist
an associated nongovernmental organiza-
tionally and advised countries as diverse as
going to great lengths to convince their tion.
Russia, Spain, and Turkey and Native
diplomatic liaisons to put aside ideologies
A subset of vaccine diplomacy is vaccine
American tribes and nations in Canada
for purposes of joint scientific cooperation
science diplomacy, which is a hybrid of
and Mexico on how to prepare and
[19–23,36]. Today, the oral polio vaccine
elements of global health diplomacy and
administer the smallpox vaccine [31,32].
is leading to global eradication efforts.
science diplomacy. I use the term ‘‘vaccine
Among the earliest examples of vaccine
Similarly, between 1962 and 1966, the
science diplomacy’’ narrowly to refer to
diplomacy, in 1801 Dr. Edward Gantt, the
USSR pioneered a freeze-drying tech-
the joint development of life-saving vac-
chaplain of the US Congress, vaccinated
nique for smallpox vaccine and provided
cines and related technologies, with the
Native American diplomats who were
450 million doses of vaccine to support
major actors typically scientists. Of partic-
visiting Washington, D.C., and in 1803
global smallpox eradication campaigns in
ular interest, the scientists may be from
the Lewis and Clark Expedition was
developing countries, while the US pro-
two or more nations that often disagree
provided smallpox vaccine intended for
vided key financial support [37]. Such
ideologically or even from nations that are
Native Americans living on the western
international collaborative efforts led to
actively engaged in hostile actions. This
frontier, although it is unclear if successful
the global eradication of smallpox by the
definition is along the lines of what Katz et
vaccinations were actually performed [32].
late 1970s, an effort led by Dr. D. A.
al. would call informal global health
From 1803 to 1815 during the Napoleonic
Henderson [37]. Later, in the 1980s and
diplomacy based on peer-to-peer scientific
wars between England and France, Jenner
following the visit of US Nobel Laureate
interactions [9], together with elements of
himself was called on for diplomatic
Fred Robbins to India, the Indo-US
science diplomacy in which the represen- functions, including prisoner releases
Vaccine Action Program (VAP) was es-
tative nation projects power through its
[31]. Jenner was honored in France and
tablished to foster international collabora-
scientific prowess and reputation, as Abel-
wrote in a letter to the National Institute of
tion in the areas of epidemiology, labora-
son and others articulated for US science
France that ‘‘the sciences are never at
tory investigation, and vaccine clinical
and applied technology during the Cold
war,’’ while Napoleon was supposed to
trials, quality control, and delivery [38].
PLOS Neglected Tropical Diseases | www.plosntds.org 2
June 2014 | Volume 8 | Issue 6 | e2808 about:blank 2/7 23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions
Table 1. Historical milestones in vaccine diplomacy. Years Specific Vaccine(s) Actions Reference 1800–1805 Smallpox
Edward Jenner promotes vaccine use in Russia, Turkey, and Spain and with Native Americans [31,32]
in the Spanish colonies of Mexico, the Five Nations of Canada, and the United States. 1801 Smallpox
The chaplain of Congress, Dr. Edward Gantt, vaccinates Native American diplomats visiting [32] Washington, D.C. 1803 Smallpox
The Lewis and Clark Expedition provides vaccine intended for Native Americans, but it is [32]
unclear if successful vaccinations were performed. 1803–1815 Smallpox
During the Napoleonic Wars, Jenner calls for prisoner release and other diplomatic functions. [31]
In a letter to the National Institute of France, he writes that ‘‘the sciences are never at war.’’ 1851 -
The First International Sanitary Conference is held in Europe. [3] 1888 -
In a speech on the inauguration of the Pasteur Institute, Louis Pasteur states, ‘‘Science knows [31,33]
no country, because knowledge belongs to humanity and is the torch which illuminates the world.’’ 1891–present -
International network of Pasteur Institutes begins, initially in Saigon, for purposes of [34]
fundamental research and research on vaccines for rabies and other infectious diseases. 1892–1897 Cholera and plague
After first testing the vaccines on himself, Dr. Waldemar Haffkine travels to India to inoculate [35]
tens of thousands of people with his prototype cholera and plague vaccines. 1902 -
Formation of the International Sanitary Bureau (present-day Pan American Health [4] Organization) 1946–48 -
Formation of the World Health Organization [3] 1956–1959 Polio
Dr. Albert Sabin travels to the USSR and collaborates with Dr. Mikhail Chumakov, ultimately [36]
testing an oral vaccine on 10 million children and then on 100 million people under the age of 20. 1962–1966 Smallpox
The USSR provides 450 million doses of vaccine for an eradication campaign, while the US [37] provides financial support. 1968 -
Formation of the Fogarty International Center of the NIH Mid-1970s Formation of PATH 1980s and 1990s Polio and other vaccines
‘‘Days of tranquility’’ for immunizations are held in more than a dozen war-torn countries. [25] 1987 -
Indo-US Vaccine Action Program (VAP) is administered under the auspices of NIAID, NIH. [38] 1990–91 -
Children’s Vaccine Initiative (CVI) 1993 -
Formation of the Sabin Vaccine Institute [58] -
Formation of the Infectious Diseases Research Institute 1997 -
Formation of the International Vaccine Institute 1997 -
Formation of the Bill & Melinda Gates Foundation 2000 -
GAVI Alliance is established, ultimately providing vaccines for North Korea. [39,41] 2001 -
‘‘Vaccine diplomacy’’ enters the literature. [19] 2007
Formation of program in Sustainable Immunization Financing at Sabin Vaccine Institute [65] 2007 Influenza
Under the auspices of the WHO, Brazil, India, Indonesia, Mexico, Thailand, and Vietnam [52]
receive US and Japanese grants for influenza vaccine manufacturing capacity and technology transfer. 2008 Yellow Fever
Outbreak of urban yellow fever—the neighboring countries of Paraguay mobilize to ensure [45]
access to yellow fever vaccine. 2009 H1N1 Influenza A
Intergovernmental Meeting (IGM) on Pandemic Influenza Preparedness Framework for the [43]
Sharing of Influenza Viruses and Access to Vaccines and Other Benefits 2010 Cholera
Call for international cholera vaccine stockpile as a humanitarian and diplomatic resource [44] 2011 -
Decade of Vaccines Collaboration [46] 2012 -
The Global Vaccine Action Plan (GVAP)—endorsed by the 194 Member States of the World [47,48] Health Assembly in May 2012 2013 Leishmaniasis and other
Joint statement on vaccine diplomacy between US and Iran [54] neglected tropical diseases 2013 -
State Department forms new Office of Global Health Diplomacy.
doi:10.1371/journal.pntd.0002808.t001
PLOS Neglected Tropical Diseases | www.plosntds.org 3
June 2014 | Volume 8 | Issue 6 | e2808 about:blank 3/7 23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions
VAP is maintained under the auspices of
developing countries [43]. Issues of devel-
science diplomacy are impressive, they
the National Institute of Allergy and
oping country access again arose when
have not yet led to an overarching
Infectious Diseases of the US National
cholera emerged in sub-Saharan Africa
framework for its expanded role in foreign
Institutes of Health (NIH) [38]. In 1990–
and Haiti; there was no mechanism to
policy. Establishing such a framework
91, a Children’s Vaccine Initiative was
rapidly mobilize cholera vaccine, and calls
might be especially useful for US foreign
launched as an early attempt at global
went out to stockpile cholera vaccine as a policy.
governance for developing pediatric vac-
humanitarian and diplomatic resource
In 2009, President Obama traveled to
cines for developing countries.
[44]. Also, in 2008 when yellow fever
Cairo where he spoke out about engaging
Vaccine diplomacy also flourished in
vaccine supplies were depleted during the
scientists in the Muslim world and extend-
the later decades of the 20th century.
first urban yellow fever outbreak in the
ing a hand in science diplomacy [53].
According to WHO’s Health as a Bridge
Americas in decades, countries neighbor-
Despite the establishment of a valuable US to Peace—Humanitarian Cease-Fires
ing Paraguay helped to ensure that the
Science Envoy program, to date such
Project (HCFP), vaccines and vaccinations
vaccine was made available in that
activities have not led to substantive joint
were used to negotiate so-called ‘‘days of
country [45]. In 2012, following the earlier
vaccine partnerships despite the observa-
tranquility’’ in more than a dozen coun-
launch of the Decade of Vaccines Collab-
tion that several Islamic countries in the
tries during the 1980s and 1990s, includ-
oration [46], the Global Vaccine Action
Middle East and Asia, including Egypt,
ing Afghanistan, Angola, Chechnya, Dem-
Plan (GVAP) was endorsed by the 194
Indonesia, Iran, and Saudi Arabia, have
ocratic Republic of Congo, El Salvador,
Member States of the World Health
some capacity for vaccine product devel-
Guinea Bissau, Iraq, Lebanon, Philip-
Assembly as ‘‘a framework to prevent
opment [23]. With an Iranian scientist
pines, Sierra Leone, Sri Lanka, and Sudan
millions of deaths by 2020 through more
from the Tehran University of Medical [25].
equitable access to existing vaccines for
Sciences, Dr. Mohammed Rokni, I re-
people in all communities’’ [47]. A World
cently advocated launching such efforts Modern Day Vaccine and
Health Assembly resolution was adopted
between the US and Iran and provided as Vaccine Science Diplomacy
that recognizes access to vaccines as a
an example the opportunity for developing
fundamental right to human health [48].
a vaccine for leishmaniasis, which has
Beginning in 2000, vaccines became
The diplomatic community was also called
devastated areas of conflict in the Middle
integrated as key tools in helping develop-
on to address critical issues of noncompli-
East and North Africa [54]. Similar
ing nations achieve their MDGs and
ance for polio and other vaccines intended
opportunities exist in order to partner
targets. Following the launch of the GAVI
for vulnerable populations living in Islamic
with nations such as Cuba, which has
Alliance, many developing countries for
countries. In 2003, a boycott of polio
considerable technical expertise both in
the first time gained access to vaccines for
vaccinations in three northern Nigerian
producing and delivering vaccine [55],
combating rotavirus and Haemophilus influ-
states from fears that the vaccine was
and possibly even countries such as North
enzae type b (Hib), and a new vaccine for
contaminated with antifertility drugs (in
Korea, which has some technical capabil-
pneumococcal vaccine was developed
order to sterilize Muslim girls) necessitated ities [56].
[39,40]. Partly because of these interven-
diplomatic intervention from the Govern-
Our Sabin Vaccine Institute and Texas
tions, child mortality was reduced by
ment of Malaysia and the OIC [49].
Children’s Hospital Center for Vaccine
almost one-half [40]. Included among
Similar interventions are now required in
Development (Sabin), a nonprofit product
these activities was GAVI’s important
Pakistan, where the Taliban and other
development partnership (PDP) that uses
work in providing vaccines for North
extremist groups have assassinated vacci-
industry practices to develop and test
Korea and other fragile states [41].
nators and other aid workers [50]. Some
neglected disease vaccines, could occupy
Among the initiatives relevant to vac-
assassinations may have been carried out
a key niche in vaccine diplomacy. Sabin’s
cine diplomacy in the 21st century are
in retaliation for the Central Intelligence
vaccine portfolio targets neglected tropical
international efforts to ensure universal or
Agency (CIA)’s alleged role in establishing
diseases (NTDs) that specifically affect the
equitable access for low- and middle-
a fake vaccination campaign in Abbotta-
poorest people living in low- and middle-
income countries to urgently needed
bad, Pakistan, as a ruse in order to confirm
income countries. Because NTDs have
vaccines for diseases of pandemic poten-
the identity of members of Osama bin
been shown to promote poverty through
tial. It was noted that many developing
Laden’s family [51]. Such activities repre-
their adverse effects on worker productiv-
countries were on the ‘‘outside looking in’’
sent a significant setback to vaccine
ity, the health of girls and women, and
when it came to having access to influenza diplomacy.
child development, the vaccines under
vaccines, including the vaccine for the
Of relevance to both vaccine and
development at Sabin are sometimes
H1N1 pandemic influenza in 2009 and
vaccine science diplomacy, in 2007 under
referred to as the ‘‘antipoverty vaccines’’
prototype H5N1 avian influenza vaccines
the auspices of the WHO and the Global
[57,58]. Moreover, most of the diseases
[42,43]. As a result, Indonesia went
Pandemic Influenza Action Plan, six
targeted by the Sabin portfolio of vaccines
through a period in which it refused to
countries—Brazil, India, Indonesia, Mex-
occur in countries of direct relevance to
share timely influenza surveillance data
ico, Thailand, and Vietnam—received
vaccine diplomacy (Table 2) [59]. For
with the WHO [42]. It was noted that
grants from the US and Japanese govern-
example, more than one-third of the
IHR 2005 did not adequately spell out
ments to establish in-country manufactur-
world’s cases of hookworm infection,
provisions on providing equitable access
ing capacity for influenza vaccines [52].
ascariasis, and trichuriasis occur in nations
for vaccines [43], and it was probably not
of the OIC, i.e., the world’s Muslim
intended for this purpose. In 2009, an Future Directions and Moving
countries (Figure 1), while almost one-half
Intergovernmental Meeting (IGM) was towards a Framework
of the cases of schistosomiasis occur
held on pandemic influenza preparedness
among the OIC countries [59]. Further-
as a means to establish a framework for
While the historical and modern-day
more, both cutaneous and visceral leish-
sharing influenza and other vaccines with
track records of vaccine and vaccine
maniasis have emerged as the most
PLOS Neglected Tropical Diseases | www.plosntds.org 4
June 2014 | Volume 8 | Issue 6 | e2808 about:blank 4/7 23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions
Figure 1. The OIC member nations. Figure adapted from Wikipedia: http://en.wikipedia.org/wiki/File:OIC_map.png.
doi:10.1371/journal.pntd.0002808.g001
significant infections arising in settings of
US in past and recent years. As a form of
Vaccine Institute (IVI) based in Seoul,
ongoing conflict, with the former affecting
projecting soft power with both allies and
Korea [62], could help mediate vaccine
hundreds of thousands of people in Syria
potential adversaries, such activities are
diplomacy between these nations. In
and Syrian refugees, while the latter was
consistent with what former Secretary
addition, Brazil, which also has major
the leading killer in the war between
Hillary Clinton termed ‘‘civilian power’’
vaccine capabilities, has initiated South-
northern and southern Sudan during the [24].
South partnerships with Lusophone Africa
1980s and 1990s [60]. Some of these
Beyond US foreign relations, there are
and could become an important actor in
diseases are also widespread in some Latin
opportunities for vaccines to promote
vaccine diplomacy [63]. Vaccine manu-
American countries where leaders have
cooperation between Asian nations. For
facturing organizations associated with
expressed varying degrees of anti-Ameri-
instance, each of the largest Asian coun-
many of the key OIC and Asian nations
can sentiment. While Sabin is currently
tries, i.e., China, India, Indonesia, Japan,
targeted for vaccine science diplomacy
conducting joint vaccine development
and Vietnam, has capabilities to develop
belong to the unique Developing Coun-
with public-sector vaccine manufacturers
and produce new vaccines [56,61]. China tries Vaccine Manufacturers Network
in Brazil and Mexico, it is ready to embark
and India engaged in overt hostilities in
(DCVMN) [64]. Both the GAVI Alliance
on joint vaccine development with coun-
1964, while China’s recent territorial
and WHO could have key roles in
tries such as Cuba, Indonesia, and Iran,
claims in the East China Sea have sparked
coordinating these activities. These orga-
i.e., nations with either strained or even
fresh tensions in the region [61]. Both
nizations also have a key role in a
overtly hostile foreign relations with the
Sabin and another PDP, the International
new Sustainable Immunization Financing
Table 2. Sabin PDP vaccines under development of potential relevance to US foreign policy interests.
Disease Targeted (Approximate Number of
Affected Geographic Areas of Interest to US People Affected) Foreign Policy Interests Stage of Development
Human hookworm infection (400 million)
OIC countries in Africa, the Middle East, and Asia Phase 1 India and China Schistosomiasis (250 million)
OIC countries in Africa and the Middle East
Completed current good manufacturing practice (cGMP) manufacture
Ascariasis and Trichuriasis (.800 million)
OIC countries in Africa, the Middle East, and Asia Preclinical India and China Leishmaniasis (10 million)
Areas of conflict in the Middle East and North Africa, Preclinical including OIC countries Chagas disease (7–8 million) Venezuela, Ecuador, Bolivia Preclinical SARS (None currently) China Preclinical
doi:10.1371/journal.pntd.0002808.t002
PLOS Neglected Tropical Diseases | www.plosntds.org 5
June 2014 | Volume 8 | Issue 6 | e2808 about:blank 5/7 23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions
throughout the world [66]. In the coming
Box 1. Potential Sites for Vaccine Diplomacy and US Foreign
years, vaccine and vaccine science diplo- Policy
macy activities could become incorporated
into the new US State Department Office A.
Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine
of Global Health Diplomacy [67], as well
Development, Houston, Texas, United States of America
as into the WHO and its regional offices B.
International Vaccine Institute, Seoul, Korea
and within organizations such as the Bill & C.
IDRI (Infectious Disease Research Institute), Seattle, Washington, United States
Melinda Gates Foundation and the Carlos of America
Slim Health Institute. The power of D.
PATH Vaccine Development Global Program, Washington, D.C., United
vaccine and vaccine science diplomacy States of America
has been underexplored despite a noble E. Finlay Institute, Havana, Cuba
track record that included promoting F. Birmex, Mexico, D.F., Mexico
peace between the Cold War powers of
the 1950s and 1960s, which also led to the G.
FIOCRUZ Bio-Manguinhos, Rio de Janeiro, Brazil
development, testing, and delivery of two H.
Instituto Butantan, Sao Paulo, Brazil
of the most important 20th century health I. Vacsera, Cairo, Egypt
interventions, i.e., the freeze-dried small- J.
Razi Vaccine and Serum Institute and Institut Pasteur, Tehran, Iran
pox vaccine and oral polio vaccine, and K. Biopharma, Bandang, Indonesia
the resulting global eradication of small-
pox and near elimination of polio. The
program inaugurated with Gates Founda-
Today, the Division of International
historical lessons from these accomplish-
tion support by Dr. Ciro De Quadros at
Relations of the NIH’s Fogarty Interna-
ments still have critical relevance to global
the Sabin Vaccine Institute, which focuses
tional Center maintains an important health and blue marble health.
on 12 African countries, five Asian coun-
role in promoting international agree-
tries, and one Central Asian country [65].
ments between the US and governments References
1. Tognotti E (2013) Lessons from the History of
global health. Bull World Health Organ 85: 230–
28. Schweitzer GE (1989) Techno-Diplomacy: US-
Quarantine, from Plague to Influenza A. Emerg 232.
Soviet Confrontations in Science and Technolo-
Infect Dis 19: 254–259. Available: http://wwwnc.
14. Labonte R, Gagnon ML (2010) Framing health
gy. New York: Plenum Pub Corp. 320 p.
cdc.gov/eid/article/19/2/12-0312_article.htm.
and foreign policy: lessons for global health
29. Zewall AH (2010) Science in diplomacy. Cell 141: Accessed 7 December 2013.
diplomacy. Global Health 6: 14. 204–207
2. Feldbaum H, Lee K, Michaud J (2010) Global
15. Kickbusch I, Lokeny M (2013) Global health
30. Federoff NV (2009) Science diplomacy in the 21st
health and foreign policy. Epidemiol Rev 32: 82–
diplomacy: five years on. Bull World Health century. Cell 136: 9–11. 92 Organ 91: 159–159A.
31. Bazin H (2000) The Eradication of Smallpox:
3. Fidler DP (2001) The globalization of public
16. Michaud J, Kates J (2013) Global health diplo-
Edward Jenner and the First and Only Eradica-
health: the first 100 years of international health
macy: advancing foreign policy and global health
tion of a Human Infectious Disease. New York:
diplomacy. Bull World Health Organ 79: 842–
interests. Glob Health Sci Pract 1: 24–28. Academic Press. 246 p. 849.
17. Hotez P (2013 March 25) The disease next door.
32. Pearson JD (2004) Medical diplomacy and the
4. Fee E, Brown T (2002) 100 years of the Pan
Foreign Policy. Available: http://www.
American Indian: Thomas Jefferson, the Lewis
American Health Organization. Am J Publ
foreignpolicy.com/articles/2013/03/25/the_
and Clark Expedition, and the subsequent effects Health 92: 1888–1889.
disease_next_door. Accessed 29 May 2014.
on American Indian health and public policy.
5. Bourne PG (1978) A partnership for international
18. Hotez PJ (2013) NTDs V.2.0: ‘‘Blue Marble Wicazo S Review 19: 105–130.
health care. Public Health Rep 93: 114–123.
Health’’—Neglected Tropical Disease Control
33. Chura L (2012) Global science can bolster
6. Hotez PJ (2013) Forgotten People, Forgotten
and Elimination in a Shifting Health Policy diplomacy. Nature 491: 527.
Diseases: The Neglected Tropical Diseases and
Landscape. PLoS Negl Trop Dis 7: e2570.
34. Pasteur International (2014) History in Move-
their Impact on Global Health and Development.
ment. Available: ht tp://www.pasteur-inter
19. Hotez PJ (2001 May–Jun) Vaccine diplomacy.
2nd Edition. Washington (D.C.): ASM Press. 275
national.org/ip/easysite/pasteur-international- Foreign Policy 124: 68–69. p.
en/institut-pasteur-international-network/
20. Hotez PJ (2001) Vaccines as instruments of
7. Michaud J, Kates J (2013) Global health diplo-
history-in-movement. Accessed 10 December
foreign policy. EMBO Rep 2: 862–868.
macy: advancing foreign policy and global health 2013.
interests. Glob Health Sci Pract 1: 24–28.
21. Hotez P (2002) Appeasing Wilson’s Ghost: The
35. Waksman SA (1964) The Brilliant and Tragic
8. Peterson S (2002) Epidemic disease and national
expanded role of the new vaccines in internation-
Life of WMW Haffkine, Bacteriologist. New
security. Security Studies 12: 43–81.
al diplomacy. In: CBACI Health and Security
Brunswick (New Jersey): Rutgers University Press.
9. Katz R, Kornblet S, Arnold G, Lief E, Fischer JE
Series. Occasional Paper 3. Washington (D.C.): 90 p.
(2011) Defining health diplomacy: changing
Chemical and Biological Arms Control Institute.
36. Swanson W (2012) Birth of a cold war vaccine.
demands in the era of globalization. Milbank Q
22. Hotez PJ (2006) The ‘‘biblical diseases’’ and US Sci Am 306: 66–69. 89: 503–523.
vaccine diplomacy. Brown J World Affairs 12:
37. Henderson DA (2009) Smallpox: the death
10. Kaufmann JR, Feldbaum H (2009) Diplomacy 247–258.
of a disease. Amherst (New York): Prometheus
and the polio immunization boycott in northern
23. Hotez PJ (2010) Peace through vaccine diploma- Books. 334 p.
Nigeria. Health Affairs 28: 1091–1101. cy. Science 327: 1301.
38. NIAID (2012) Indo-U.S. Vaccine Action Pro-
11. Fidler DP (2010) Negotiating equitable access to
24. Hotez PJ (2011) Unleashing ‘‘civilian power’’: a
gram (VAP). Available: http://www.niaid.nih.
influenza vaccines: global health diplomacy and
new American diplomacy through neglected
gov/about/organization/dmid/indo/Pages/
the controversies surrounding avian influenza
tropical disease control, elimination, research,
default.aspx. Accessed 25 January 2014.
H5N1 and pandemic influenza H1N1. PLoS
and development. PLoS Negl Trop Dis 5: e1134.
39. Gavi Alliance (2014) Gavi Alliance. Available: Med 7: e1000247.
25. World Health Organization (2014) Health as a
http://www.gavialliance.org. Accessed 10 De-
12. Foreign Ministers of Brazil, France, Indonesia,
Bridge for Peace - HUMANITARIAN CEASE- cember 2013.
Norway, Senegal, South Africa, and Thailand
FIRES PROJECT (HCFP). Available: http://
40. Hotez PJ (2013) Pediatric Tropical Diseases and
(Oslo) (2007) Oslo Ministerial Declaration—
www.who.int/hac/techguidance/hbp/cease_
the World’s Children Living in Extreme Poverty.
Global health: A pressing foreign policy issue of
fires/en/#. Accessed 25 January 2014. J Appl Res Child 4: 10.
our time. Lancet 369: 1373–1378.
26. Abelson PH (1972) Science, technology, and
41. Gavi Alliance (2014) Korea, Democratic People’s
13. Kickbusch I, Silberschmidt G, Buss P (2007) diplomacy. Science 178: 701.
Republic of (the). Available: http://www.
Global health diplomacy: the need for new
27. Rabkin YM (1988) Sciences between the super-
gavialliance.org/country/dpr-korea. Accessed 10
perspectives, strategic approaches and skills in
powers. New York: Priority Press. 119 p. December 2013.
PLOS Neglected Tropical Diseases | www.plosntds.org 6
June 2014 | Volume 8 | Issue 6 | e2808 about:blank 6/7 23:47 29/7/24
Vaccine Diplomacy-Historical Perspectives and Future Directions
42. Fidler DP (2008) Influenza virus samples, inter-
campaign-endangers-us-all. Accessed 14 Decem-
sation of the Islamic Conference. PLoS Negl
national law, and global health diplomacy. Emerg ber 2013.
Trop Dis 3: e539. doi: 10.1371/journal.pntd. Infect Dis 14: 88–94
51. Shah S (2011 July 11) CIA organized fake 0000539
43. Fidler DP (2010) Negotiating equitable access to
vaccination drive to get Osama bin Laden’s
60. Hotez PJ (2013 July 19) Another bad thing about
influenza vaccines: global health diplomacy and
family DNA. The Guardian. Available: http://
war: insect-borne diseases. Global Post. Available:
the controversies surrounding avian influenza
www.theguardian.com/world/2011/jul/11/cia-
h t t p : / / w w w . g lo b a l p o s t . c o m / d is p a t c h e s /
H5N1 and pandemic influenza H1N1. PLoS
fake-vaccinations-osama-bin-ladens-dna. Ac-
globalpost-blogs/commentary/insect-borne- Med 7: e1000247. cessed 14 December 2013.
diseases-wars-mideast-africa-leishmania sis-
44. Waldor MK, Hotez PJ, Clemens JD (2010) A
52. World Health Organization (2007 April 24) chagas. Accessed 29 May 2014.
national cholera vaccine stockpile – a new
WHO facilitates influenza vaccine technology
61. Hotez P, Singh SK, Zhou XN (2013) Advancing
humanitarian and diplomatic resource.
transfer to developing countries. Available:
Sino-Indian cooperation to combat tropical N Engl J Med 363: 2279–2282.
http://who.int/mediacentre/news/notes/2007/
diseases. PLoS Negl Trop Dis 7: e2204.
45. Andrus JK, Ropero AM, Ghisays G, Romero S,
np18/en/index.html. Accessed 25 January 2014.
62. International Vaccine Initiative (2012) Training
Jauregui B, et al. (2011) Yellow fever and health
53. Koenig R (2009) US takes steps to use science to
and Technical Assistance. Available: http://
diplomacy: International efforts to stop the urban
improve ties to Muslim world. Science 326: 920–
www.ivi.int/web/www/02_07_03. Accessed 14
yellow fever outbreak in Paraguay. In: Rosskam 921. December 2013.
E, Kickbusch I, editors. Negotiating and Navi-
54. Hotez PJ, Rokni MB (2013 November 6) Next
gating Global Health: Case Studies in Global
steps in U.S.-Iran diplomacy: vaccines. Pacific
63. Almedia C, Pires de Campos R, Buss P, Ferreira
Health Diplomacy. Singapore: World Scientific
Standard. Available: http://www.psmag.com/
JR, Fonseca LE (2009) Brazil’s conception of
Publishing Company. pp. 391–403.
navigation/health-and-behavior/next-steps-u-s-
South-South ‘‘structural cooperation’’ in health.
46. Decade of Vaccines (2014) Vision. Available:
iran-diplomacy-vaccines-69542/. Accessed 29
Fiocruz. Available: http://www6.ensp.fiocruz.br/
http://www.dovcollaboration.org/about-us/ May 2014.
repositorio/sites/default/files/arquivos/343-
vision/. Accessed 25 January 2014.
55. Andrus JK, de Quadros CA, Castillo Slorzano C,
1635-2-PB.pdf. Accessed 14 December 2013.
47. World Health Organization (2014) Decade of
Roses Periago M, Henderson DA (2011) Measles
64. DCVMN (2014) Members. Available: http://
Vaccines—Global Vaccine Action Plan 2011–
and rubella eradication in the Americas. Vaccine
www.dcvmn.org/members. Accessed 14 Decem-
2 0 2 0 . A v a i l a b l e: h t t p : / / w w w . w h o . in t / 295: D91–D96. ber 2013.
immunization/global_vaccine_action_plan/en/.
56. Hotez PJ (2013 January 24) A reunification Rx for
65. Sabin Vaccine Institute (2014) Sustainable Im- Accessed 25 January 2014.
Korea. Los Angeles Times. Available: http://
munization Financing (SIF) Program. Available:
48. World Health Organization (2014) World Health
articles.latimes.com/2013/jan/24/opinion/la-
http://www.sabin.org/programs/vaccine-
Assembly Resolution. Available: http://www.
oe-hotez-korea-vaccine-diplomacy-20130124.
advocacy-education/sustainable-immunization-
who.int/immunization/global_vaccine_action_ Accessed 29 May 2014.
financing-sif-program. Accessed 25 January 2014.
p l a n / G V A P _ _ W o r l d _ H e a l t h _ A s s e m b l y _
57. Hotez PJ, Ferris MT (2006) The antipoverty
66. Fogarty International Center (2014) Division of
Resolution.pdf. Accessed 25 January 2014
vaccines. Vaccine 24: 5787–5799.
International Relations (DIR). Available: http://
49. Kaufmann JR, Feldbaum H (2009) Diplomacy
58. Hotez P (2011) A handful of ‘antipoverty’
www.fic.nih.gov/About/Staff/Pages/International-
and the polio immunization boycott in northern
vaccines exist for neglected diseases, but the
Relations.aspx. Accessed 25 January 2014.
Nigeria. Health Affairs 28: 1091–1101.
world’s poorest billion people need more. Health
67. US Department of State (2014) Office of Global
50. Scientific American (2013 April 16) How the
Aff (Millwood) 30: 1080–1087.
Health Diplomacy. Available: http://www.state.
CIA’s Fake Vaccination Campaign Endangers Us
59. Hotez PJ (2009) The Neglected Tropical Diseases
gov/s/ghd/. Accessed 14 December 2013.
All. Available: http://www.scientificamerican.
and Their Devastating Health and Economic
com/article.cfm?id = how-cia-fake-vaccination-
Impact on the Member Nations of the Organi-
PLOS Neglected Tropical Diseases | www.plosntds.org 7
June 2014 | Volume 8 | Issue 6 | e2808 about:blank 7/7